ArticleComputational and structural biotechnology journal2025
Ubigo-X: Protein ubiquitination site prediction using ensemble learning with image-based feature representation and weighted voting.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep learning-driven decoding of ubiquitination: from regulatory mechanisms to targeted protein degradation.Biology direct · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate ubiquitination identification is crucial in biological function analysis. We developed Ubigo-X, a novel protein ubiquitination prediction tool. Our training data, sourced from the Protein Lysine Modification Database (PLMD 3.0), comprised 53,338 ubiquitination and 71,399 non-ubiquitination sites, retained after CD-HIT and CD-HIT-2d sequence filtering. Three sub-models: Single-Type sequence-based features (Single-Type SBF), k-mer sequence-based features (Co-Type SBF), and structure-based and function-based features (S-FBF), were developed. Single-Type SBF used amino acid composition (AAC), amino acid index (AAindex), and one-hot encoding; Co-Type SBF used Single-Type SBF via k-mer encoding; and S-FBF used secondary structure, relative solvent accessibility (RSA)/absolute solvent-accessible area (ASA), and signal peptide cleavage sites. S-FBF was trained using XGBoost, while Single-Type SBF and Co-Type SBF were transformed into image-based features and trained using Resnet34. Ubigo-X was developed by combining the three models via a weighted voting strategy. Independent testing using PhosphoSitePlus data (65,421 ubiquitination and 61,222 non-ubiquitination sites) retained after filtering yielded 0.85, 0.79, and 0.58 for area under the curve (AUC), accuracy (ACC), and Matthews correlation coefficient (MCC), respectively. Further testing on imbalanced PhosphoSitePlus data (1:8 positive-to-negative sample ratio) yielded 0.94 AUC, 0.85 ACC, and 0.55 MCC. Using the GPS-Uber data, the AUC, ACC, and MCC were 0.81, 0.59, and 0.27, respectively. In conclusion, Ubigo-X outperformed existing tools in MCC (for both balanced and unbalanced data) and AUC and ACC (for balanced data), highlighting the efficacy of integrating image-based feature representation and weighted voting in ubiquitination prediction. Ubigo-X is a potential species-neutral ubiquitination site prediction tool, accessible at http://merlin.nchu.edu.tw/ubigox/.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.